NOS+SARS-CoV-2 Pathogenesis
Roman Gurinovich
Yuliya Buinitskaya
10.6084/m9.figshare.12034962.v1
https://figshare.com/articles/preprint/NOS_SARS-CoV-2_Pathogenesis/12034962
<div>
<div>
<div>
<div>
<p>COVID-19 aggravates already compromised NO production in cohort
with NOS3 polymorphism. Management of eNOS/iNOS ratio and NO level
can prevent development of severe ARDS.
</p>
</div>
</div>
</div>
</div>
2020-03-26 17:24:47
SARS-CoV-2
covid-19
nitric oxide
polymorphism
ARDS
italian
NOS
Clinical Microbiology
Clinical Pharmacology and Therapeutics
Diseases
Intensive Care
Medical Virology
Molecular Targets